Henan Shuanghe Huali Pharmaceutical Co., Ltd.
-
Founded in:
2011-09-30 -
Country:
China -
Address:
No. 369 Qinggong Road, Pingdingshan City -
Tax NO.:
91410400582895296J -
Registered Funds:
118 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Xylitol |
It is a nutritional medicine that can supplement calories and improve sugar metabolism. Its metabolism in the body does not rely on the participation of insulin. It directly participates in sugar metabolism through the cell membrane without increasing blood sugar concentration. Its sweetness and heat generation are similar to those of glucose. It can be used as a sugar substitute for diabetic patients. In addition, it has the effect of inhibiting the production of ketone bodies and can reduce the production of plasma fatty acids. It can be used as a combined drug for diabetes and ketoacidosis during surgical anesthesia.
More
It is a nutritional medicine that can supplement calories and improve sugar metabolism. Its metabolism in the body does not rely on the participation of insulin. It directly participates in sugar metabolism through the cell membrane without increasing blood sugar concentration. Its sweetness and heat generation are similar to those of glucose. It can be used as a sugar substitute for diabetic patients. In addition, it has the effect of inhibiting the production of ketone bodies and can reduce the production of plasma fatty acids. It can be used as a combined drug for diabetes and ketoacidosis during surgical anesthesia. |
87-99-0 | 15 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Troxerutin |
It can inhibit platelet aggregation and prevent thrombosis. It can also counteract vascular damage caused by 5-hydroxytryptamine and bradykinin, increase capillary resistance, reduce capillary permeability, and prevent edema caused by increased vascular permeability.
More
It can inhibit platelet aggregation and prevent thrombosis. It can also counteract vascular damage caused by 5-hydroxytryptamine and bradykinin, increase capillary resistance, reduce capillary permeability, and prevent edema caused by increased vascular permeability. |
7085-55-4 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium bicarbonate |
1. Treat metabolic acidosis. This product increases the concentration of carbonate in plasma and neutralizes hydrogen ions, thereby correcting acidosis. 2. Alkalinize urine. As the pH value increases after the concentration of bicarbonate in urine increases, uric acid, sulfonamide drugs and hemoglobin are not easy to form crystals or aggregate in urine. 3. Antacid. Oral administration can quickly neutralize or buffer gastric acid without directly affecting gastric acid secretion. Therefore, the pH in the stomach increases rapidly to relieve the symptoms caused by high gastric acid.
More
1. Treat metabolic acidosis. This product increases the concentration of carbonate in plasma and neutralizes hydrogen ions, thereby correcting acidosis. 2. Alkalinize urine. As the pH value increases after the concentration of bicarbonate in urine increases, uric acid, sulfonamide drugs and hemoglobin are not easy to form crystals or aggregate in urine. 3. Antacid. Oral administration can quickly neutralize or buffer gastric acid without directly affecting gastric acid secretion. Therefore, the pH in the stomach increases rapidly to relieve the symptoms caused by high gastric acid. |
144-55-8 | 47 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Metronidazole |
This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. It has a strong killing effect on trichomonas, and its mechanism is unknown. It has a killing effect on anaerobic microorganisms. The metabolites generated during reduction in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death.
More
This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. It has a strong killing effect on trichomonas, and its mechanism is unknown. It has a killing effect on anaerobic microorganisms. The metabolites generated during reduction in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. |
0.2% | 443-48-1 | 39 |
| GLUCOSE |
This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. Metronidazole is carcinogenic to some animals.
More
This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. Metronidazole is carcinogenic to some animals. |
5% | 58367-01-4 | 15 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium chloride |
Maintains normal blood and extracellular fluid volume and osmotic pressure in the human body, and plays a decisive role in osmotic pressure
More
Maintains normal blood and extracellular fluid volume and osmotic pressure in the human body, and plays a decisive role in osmotic pressure |
0.85% | 7647-14-5 | 43 |
| Potassium chloride |
Supplement a small amount of potassium ions to maintain the stability of body fluid volume and osmotic pressure
More
Supplement a small amount of potassium ions to maintain the stability of body fluid volume and osmotic pressure |
0.03% | 7447-40-7 | 39 |
| Calcium chloride |
Supplement a small amount of calcium ions to maintain the stability of body fluid volume and osmotic pressure
More
Supplement a small amount of calcium ions to maintain the stability of body fluid volume and osmotic pressure |
0.033% | 10043-52-4 | 29 |